BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Neocentromeres
,
Ciprofibrate
,
rs2300478
,
PRKCA
,
G-protein-coupled receptor binding
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
TBL1XR1
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Thyroid gland
Thymus gland
Breast tissue
Nipple cross-section
Fallopian tube
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Irritable bowel syndrome
Chronic fatigue syndrome
Pneumocystosis
Kidney disease
Intestinal infectious disease
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Tremorine
methylazoxymethanol
MG 0103
rauwolscine-OHPC
Methylnitronitrosoguanidine
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
NOL4L
AHI1
FAM198B
PDE10A
ECH1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Deficiency of TBL1XR1 causes asthenozoospermia.
Expanding the genotypic and phenotypic spectrum associated with TBL1XR1 de novo variants.
A novel fusion protein TBLR1-RARα acts as an oncogene to induce murine promyelocytic leukemia: ident…
MicroRNA-34c-5p Reduces Malignant Properties of Lung Cancer Cells through Regulation of TBL1XR1/Wnt/…
LINC01578 affects the radiation resistance of lung cancer cells through regulating microRNA-216b-5p/…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Molecular Prognosis of Lymphomas of the Central Nervous System (ALYCE-molecular)
A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Ce…
Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With T…
A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ